Alyacen 7/7/7 Tablets
Glenmark is recalling Alyacen 7/7/7 tablets due to out-of-specification results for total impurities.
Contact your healthcare provider or pharmacist if you have questions or concerns regarding your medication. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Glenmark Pharmaceuticals is recalling Alyacen 7/7/7 (Norethindrone and Ethinyl Estradiol) tablets due to out-of-specification results for total impurities. The affected product consists of 3-blister card packs, each containing a 28-day regimen.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP
- Lot code
- 20240411, 2026
- Strength
- 0.5 mg
- UPC
- 20240411, 20250252
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Impurity or Degradation recalls
Other recent recalls from Glenmark Pharmaceuticals Inc., USA
Editorial summary by Recall Canary · summary updated 2026-06-13 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification